• Aerial Biopharma LLC, of Morrisville, N.C., reported results from a 12-week, 93-patient Phase IIb study of ADX-NO5 in with excessive daytime sleepiness associated with narcolepsy, which the company said validates data from a Phase IIa proof-of-concept trial in a larger patient population with a longer duration of treatment.